Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 17,289 shares at $14.79 ($255K) on 2019-10-01, disclosed to the SEC on 2019-10-03.
Open-market sale of $255k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.79 | 7,289 | $108K | 42.3% |
| 2 | $14.79 | 7,289 | $108K | 42.3% |
| 3 | $14.57 | 1,102 | $16K | 6.3% |
| 4 | $14.27 | 1,609 | $23K | 9.0% |
| Total | $14.73 avg | 17,289 | $255K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |